Výsledky vyhledávání

In this theoretical analysis, we argue that a process referred to as minding is essential for a couple to feel mutually close and satisfied in a close relationship overa long period. Minding represents a package of mutual self-disclosure, other forms

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39991c3988c84577cbc8137b44218069
https://doi.org/10.1207/s15327957pspr0103_3

Zobrazit plný text záznamu

A randomized phase IItrial of mapatumumab, a TRAIL R1 agonist monoclonal antibody, in combination with carboplatin and paclitaxel in patients with advanced NSCLC

Autor: Martin Reck, J. von Pawel, J. H. Harvey, E Kumm, Gilles Gallant, Mircea Dediu, C. L. Cebotaru, D. R. Camidge, N. L. Fox, David R. Spigel

Publikováno v: Pneumologie. 65

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5a22029a9eef78038e89d2703ad4d4f1
https://doi.org/10.1055/s-0031-1272244

Zobrazit plný text záznamu

VACCINES IN THE TREATMENT OF CHRONIC BRONCHITIS AND OF ASTHMA

Autor: J. H. Harvey Pirie

Publikováno v: British medical journal. 1(2737)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2fa15180d76d48174ce8abdd56297fc
https://pubmed.ncbi.nlm.nih.gov/20766686

Zobrazit plný text záznamu

Sense of coherence moderates the relationship between life stress and natural killer cell activity in healthy older adults

Autor: S K, Lutgendorf, P P, Vitaliano, T, Tripp-Reimer, J H, Harvey, D M, Lubaroff

Publikováno v: Psychology and aging. 14(4)

A sense of coherence (SOC) has been found to be a strong predictor of health outcomes and life satisfaction in older adults. This study investigated mood and immune effects of anticipated voluntary housing relocation in 30 healthy older adults and 28

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::6a81356d1d44eac11dab0ec73ba23550
https://pubmed.ncbi.nlm.nih.gov/10632144

Zobrazit plný text záznamu

A randomized phase II trial of mapatumumab, a TRAIL-R1 agonist monoclonal antibody, in combination with carboplatin and paclitaxel in patients with advanced NSCLC

Autor: Gilles Gallant, D. R. Camidge, C. L. Cebotaru, N. L. Fox, E Kumm, J. von Pawel, Martin Reck, David R. Spigel, Mircea Dediu, J. H. Harvey

Publikováno v: Journal of Clinical Oncology. 28:LBA7501-LBA7501

LBA7501 Background: Mapatumumab, a fully human agonist monoclonal antibody, targets and activates the death receptor TRAIL-R1. We conducted this randomized, controlled phase II trial to evaluate mapatumumab in combination with carboplatin and paclita

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::19a7081e627e40acb1f299008afaeea6
https://doi.org/10.1200/jco.2010.28.18_suppl.lba7501

Zobrazit plný text záznamu